Dexamethasone palmitate

Dexamethasone palmitate (CAS No.: 14899-36-6) is a synthetic lipophilic corticosteroid ester and prodrug derivative of dexamethasone that is primarily categorized as a glucocorticoid receptor modulating research tool for inflammation and immune signaling studies in biomedical and drug discovery settings, where it is used to examine corticosteroid responsive transcriptional programs and downstream suppression of pro inflammatory mediators through glucocorticoid receptor dependent mechanisms including receptor activation, nuclear translocation, and regulation of NF kappa B and AP 1 associated signaling networks; available evidence indicates that this molecule acts as a glucocorticoid receptor agonist with substantially reduced direct receptor affinity relative to dexamethasone, reported at approximately 47 fold lower binding strength, consistent with a prodrug like functional profile that can influence apparent potency depending on metabolic context and model system, and in vitro activity is therefore generally interpreted in broad concentration windows from nanomolar to micromolar range rather than as a single fixed potency value across platforms; in research practice it is commonly applied in cellular inflammation models, macrophage or immune cell stimulation paradigms, and preclinical animal experiments designed to characterize inflammatory biology, pharmacodynamic responses, or formulation driven delivery behavior, while concentration and dose selection are determined by specific experimental design, matrix, exposure duration, and study objectives, making dexamethasone palmitate a relevant compound for mechanistic studies, comparative corticosteroid profiling, and nonclinical screening workflows focused on inflammation related pathways.